ST DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA has a total of 30 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, Chile and Nicaragua. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CONSTELLATION PHARMACEUTICALS INC, OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTPR and EHJSAJ AR EHND DI MENEDZHMENT KO LTD.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Sugars | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Narjes Frank | 13 |
#2 | Stansfield Ian | 9 |
#3 | Habermann Joerg | 6 |
#4 | Rowley Michael | 5 |
#5 | Jones Philip | 5 |
#6 | Conte Immacolata | 5 |
#7 | Pacini Barbara | 3 |
#8 | Monaci Paolo | 3 |
#9 | Koch Uwe | 3 |
#10 | Mackay Angela Claire | 3 |
Publication | Filing date | Title |
---|---|---|
AU2005298412A1 | Tetracyclic indole derivatives as antiviral agents | |
AU2005221864A1 | HIV integrase inhibitors | |
AU2004238979A1 | Broadening adenovirus tropism | |
AU2003294023A1 | Rhesus HER2/neu, nucleotides encoding same, and uses thereof |